Evidence map›Paper›PMID 25210892›Full record

ArticlePloS one2014

The ocular benefits of estrogen replacement therapy: a population-based study in postmenopausal Korean women.

Kyung-Sun Na, Dong Hyun Jee, Kyungdo Han, Yong-Gyu Park, Man Soo Kim, Eun Chul Kim

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. [Gender medicine in ophthalmology : The "small difference" between women and men].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020
    Article
  11. Article
  12. Eye diseases in women.Fukushima journal of medical science · 2019
    Review
  13. Article
  14. Article
  15. Gonadal Hormones and Retinal Disorders: A Review.Frontiers in endocrinology · 2018
    Review
  16. Article
  17. Article
  18. Protective effect ofAnatomy & cell biology · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kyung-Sun NaDepartment of Ophthalmology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Dong Hyun JeeDepartment of Ophthalmology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kyungdo HanDepartment of Biostatistics, The Catholic University of Korea, Seoul, Korea.
Yong-Gyu ParkDepartment of Biostatistics, The Catholic University of Korea, Seoul, Korea.
Man Soo KimDepartment of Ophthalmology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Eun Chul KimDepartment of Ophthalmology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Catholic University of Korea · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo elucidate the prevalence of cataract, glaucoma, pterygia, and diabetic retinopathy among Korean postmenopausal women with or without estrogen replacement therapy (ERT).

methodsA cross-sectional, nationally representative sample from the 4th Korea National Health and Nutrition Examination Survey (KNHANES IV) (2007-2009) was used. Participants were interviewed for the determination of socioeconomic and gynecologic factors. Each woman also underwent an ophthalmologic examination and provided a blood sample for risk factor assessment.

resultsOf 3968 postmenopausal women enrolled, 3390 had never received estrogen, and 578 were undergoing estrogen treatment. After adjusting for age, diabetes, hypertension, high cholesterol levels, and high low-density lipoprotein levels, the prevalence of anterior polar cataract, retinal nerve fiber layer (RNFL) defect, and flesh pterygium was higher in the non-ERT group (OR, 3.24; 95% CI, 1.12-9.35, OR 1.70; 95% CI, 1.04-2.78, OR 3.725; 95% CI, 1.21-11.45, respectively). Further, the prevalence of atrophic pterygium was lower in the non-ERT group compared to that in the ERT group (OR, 0.21, 95% CI, 0.07-0.63).

conclusionsThese data suggest that ERT has a protective effect against the development of anterior polar cataract, flesh pterygium, and RNFL defect.

Indexed as

Estrogen Replacement TherapyPostmenopauseAgedCataractDiabetic RetinopathyEstrogensFemaleGlaucomaHumansMiddle AgedPrevalencePterygiumRepublic of KoreaEstrogens

Identifiers

PMID25210892
PMCPMC4161336
OpenAlexW1974845698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.